Ultrapure filter does not confer short-term benefits over two reverse osmosis systems in chronic hemodialysis patients

Ayelet Grupper*, Moshe Shashar, Talia Weinstein, Orit Kliuk Ben Bassat, Shoni Levy, Idit F. Schwartz, Avital Angel, Aharon Baruch, Avishay Grupper, Gil Chernin, Doron Schwartz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: Dialysate purity contributes to the inflammatory response that afflicts hemodialysis patients. Objectives: To compare the clinical and laboratory effects of using ultrapure water produced by a water treatment system including two reverse osmosis (RO) units in series, with a system that also includes an ultrapure filter (UPF). Methods: We performed a retrospective study in 193 hemodialysis patients during two periods: period A (no UPF, 6 months) and period B (same patients, with addition of UPF, 18 months), and a historical cohort of patients treated in the same dialysis unit 2 years earlier, which served as a control group. Results: Mean C-reactive protein, serum albumin and systolic blood pressure worsened in period B compared to period A and in the controls. Conclusions: A double RO system to produce ultrapure water is not inferior to the use of ultrapure filters.

Original languageEnglish
Pages (from-to)5-9
Number of pages5
JournalIsrael Medical Association Journal
Volume21
Issue number1
StatePublished - Jan 2019

Keywords

  • Hemodialysis
  • Reverse osmosis (RO)
  • Ultrapure filters (UPF)
  • Ultrapure water, water treatment system

Fingerprint

Dive into the research topics of 'Ultrapure filter does not confer short-term benefits over two reverse osmosis systems in chronic hemodialysis patients'. Together they form a unique fingerprint.

Cite this